| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/09/2007 | US20070185018 Use of secretin in treatments of disorders associated with the amygdala |
| 08/09/2007 | US20070185013 Use of chk1 inhibitors to control cell proliferation |
| 08/09/2007 | US20070185010 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184465 Methods for regulating hematopoiesis using CpG-oligonucleotides |
| 08/09/2007 | US20070184461 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/09/2007 | US20070184112 Volume Efficient Controlled Release Dosage Form |
| 08/09/2007 | US20070184109 Compositions comprising triptans and nsaids |
| 08/09/2007 | US20070184097 Adhesive preparations |
| 08/09/2007 | US20070184061 Indolylmaleimide derivatives |
| 08/09/2007 | US20070184058 Glucocerebroside treatment of pulmonary or respiratory diseases or disorders |
| 08/09/2007 | US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same |
| 08/09/2007 | CA2641815A1 Method of treatment for muscular dystrophy |
| 08/09/2007 | CA2640955A1 Upregulation of adamts4 protease activity for the treatment of alzheimer's disease |
| 08/09/2007 | CA2640615A1 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 08/09/2007 | CA2640598A1 Liposome preparation |
| 08/09/2007 | CA2640584A1 Cationic steroid antimicrobial compositions and methods of use |
| 08/09/2007 | CA2637826A1 Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist |
| 08/09/2007 | CA2637329A1 Nutritional system and methods for increasing longevity |
| 08/09/2007 | CA2635718A1 Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders |
| 08/09/2007 | CA2633762A1 Unit dose comprising water-insoluble inorganic phosphate binder |
| 08/08/2007 | EP1815868A2 Drug absorptivity improving agent |
| 08/08/2007 | EP1815867A1 Combination drug for treating autoimmune disease |
| 08/08/2007 | EP1815866A1 Remedy or preventive for ischemic cardiac disease or ischemic cardiac myopathy |
| 08/08/2007 | EP1815860A2 Phosphate transport inhibitors |
| 08/08/2007 | EP1815858A2 Association between a peroxisome proliferator-activated receptor ligand and an antioxidant agent and the pharmaceutical compositions that contain them |
| 08/08/2007 | EP1815855A1 Pharmaceutical composition for modified release insulin sensitiser |
| 08/08/2007 | EP1815852A1 Nonaqueous preparation for percutaneous absorption containing nonsteroidal antiflammatory analgesic |
| 08/08/2007 | EP1814590A2 Treatment of obesity and related disorders |
| 08/08/2007 | EP1814588A2 Antiinfective lipopeptides |
| 08/08/2007 | EP1814560A2 Antibiotic compounds, compositions and medical uses |
| 08/08/2007 | EP1814549A2 Method for treating hiv infection through co-administration of tipranavir and uk-427, 857 |
| 08/08/2007 | EP1814543A2 Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
| 08/08/2007 | EP1682499B1 4-biarylyl-1-phenylazetidin-2-ones |
| 08/08/2007 | EP1658083B1 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids |
| 08/08/2007 | EP1553950B1 Therapeutic treatment |
| 08/08/2007 | EP1482938B1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
| 08/08/2007 | EP1451219B1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
| 08/08/2007 | EP1441717B1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog |
| 08/08/2007 | EP1315509B1 Nitrogen oxide for use in the treatment of drug resistant organisms |
| 08/08/2007 | EP1267616B1 Methods of increasing hair growth by wnt polypeptide |
| 08/08/2007 | EP1083914B1 Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions |
| 08/08/2007 | EP1071425B1 Treatment of depression and pharmaceutical preparations therefor |
| 08/08/2007 | EP0981372B1 Compositions of antichlamydial agents for the diagnosis and management of infection caused by chlamydia |
| 08/08/2007 | EP0706376B2 Anti-angiogenic compositions and methods of use |
| 08/08/2007 | CN1330668C Antibodies to insulin-like growth factor I receptor |
| 08/08/2007 | CN1330649C Carbamate-substituted pyrazolopyridines |
| 08/08/2007 | CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 08/08/2007 | CN1330378C 药物组合物 The pharmaceutical composition of |
| 08/08/2007 | CN1330308C Use of 4-pyridylmethylphthalazines for cancer treatment |
| 08/08/2007 | CN1330307C Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/08/2007 | CN101014613A Chimpanzee adenovirus vaccine carriers |
| 08/08/2007 | CN101014369A Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist |
| 08/08/2007 | CN101014368A Combination of organic compounds. |
| 08/08/2007 | CN101014354A A method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture |
| 08/08/2007 | CN101014335A Combinations of a cholesterol biosynthesis inhibitor and a soluble fiber for the treatment of conditions associated with elevated cholesterol levels |
| 08/08/2007 | CN101014329A Method of effectively using medicine and method concerning prevention of side effect |
| 08/08/2007 | CN101012259A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
| 08/08/2007 | CN101011584A Method for achieving persistent transgene expression |
| 08/08/2007 | CN101011578A Antimicrobial medicament preparation with polyanhydrides as vector and its preparing process |
| 08/08/2007 | CN101011576A Compositions and methods for treating or preventing inflammatory diseases |
| 08/08/2007 | CN101011575A RNA interference medicament for preventing and treating atherosclerosis |
| 08/08/2007 | CN101011390A Use of angiotensin II receptor antagonists for treating acute myocardial infarction |
| 08/08/2007 | CN101011360A Recipe composition of dry turbid agent and its preparation process |
| 08/08/2007 | CN101011356A Aerosol and its preparation |
| 08/08/2007 | CN101011355A Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 08/08/2007 | CN101011353A Anti-cancer composition loading both platinum compound and alkylating agent |
| 08/08/2007 | CN101011352A Anti-cancer composition loading both mtrosourea medicament and guanopterin analog |
| 08/08/2007 | CN101011351A Anti-cancer composition loading both platinum compound and synergist |
| 08/08/2007 | CN101011350A Anti solid tumor composition |
| 08/08/2007 | CN101011349A Slow release injection containing mtrosourea medicament and topoisomerase inhibitor |
| 08/08/2007 | CN101011348A Anti-cancer composition loading both mtrosourea medicament and alkaloids medicament |
| 08/08/2007 | CN101011347A Slow release injection containing platinum compound and topoisomerase inhibitor |
| 08/08/2007 | CN101011346A Anti-cancer composition loading both mtrosourea medicament and synergist |
| 08/08/2007 | CN101011345A Slow release injection containing platinum compound and alkylating agent |
| 08/08/2007 | CN101011344A Anti-cancer composition loading both mtrosourea medicament and alkylating agent |
| 08/08/2007 | CN101011343A Slow release injection containing anti-metabolism medicament and alkylating agent |
| 08/08/2007 | CN101011342A Slow release injection containing anti-metabolism medicament and platinum compound |
| 08/08/2007 | CN101011341A Slow release injection containing anti-metabolism medicament and topoisomerase inhibitor |
| 08/08/2007 | CN101011340A Anti-cancer composition loading both anti-metabolism medicament and alkylating agent |
| 08/07/2007 | WO2007091338A1 Composition for prevention of recurrence of stroke |
| 08/07/2007 | US7253281 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea |
| 08/07/2007 | US7253190 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 08/07/2007 | US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid |
| 08/07/2007 | US7253169 Aza compounds, pharmaceutical compositions and methods of use |
| 08/07/2007 | US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other |
| 08/07/2007 | US7253007 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 08/07/2007 | US7252974 Human growth gene and short stature gene region |
| 08/07/2007 | US7252934 Synergistic activation of regulatory elements by Rel proteins and a steroid receptor |
| 08/07/2007 | US7252846 Topical composition and method for the treatment and prophylaxis of dermal irritations |
| 08/07/2007 | US7252838 Ligating band also may include an inner diffusion barrier disposed between the elastomeric layer and the inner drug releasing layer |
| 08/07/2007 | US7252825 MAGE-3 peptides presented by HLA class II molecules |
| 08/07/2007 | US7252817 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells |
| 08/07/2007 | CA2571462A1 Composition for preventing recurrence of stroke |
| 08/07/2007 | CA2424242C Methods for treating muscle injuries |
| 08/07/2007 | CA2369810C Method of treating pain |
| 08/07/2007 | CA2351536C Therapeutic anti-fungal nail preparation |
| 08/07/2007 | CA2340636C Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 08/07/2007 | CA2324887C Ophthalmic composition comprising a .beta.-blocker |
| 08/07/2007 | CA2281946C Pharmaceutical formulations containing poorly soluble drug substances |